[1]
|
Studer, L.L. and Selby, D.M. (2018) Hepatic Epithelioid Hemangioendothelioma. Archives of Pathology & Laboratory Medicine, 142, 263-267. https://doi.org/10.5858/arpa.2016-0171-RS
|
[2]
|
Treska, V., Daum, O., Svajdler, M., Liska, V., Ferda, J. and Baxa, J. (2017) Hepatic Epithelioid Hemangioendothelioma—A Rare Tumor and Diagnostic Dilemma. In Vivo, 31, 763-767. https://doi.org/10.21873/invivo.11128
|
[3]
|
Saste, A., Cabrera Fernandez, D.F., Gulati, R. and Gamalski, S. (2015) A Trimodality Approach in the Management of Metastatic Low-Grade Epithelioid Hemangioendothelioma of the Bone. BMJ Case Reports, 2015, bcr2015210196. https://doi.org/10.1136/bcr-2015-210196
|
[4]
|
Lau, A., Malangone, S., Green, M., Badari, A., Clarke, K. and Elquza, E. (2015) Combination Capecitabine and Bevacizumab in the Treatment of Metastatic Hepatic Epithelioid Hemangioendothelioma. Therapeutic Advances in Medical Oncology, 7, 229-236. https://doi.org/10.1177/1758834015582206
|
[5]
|
Zheng, Z., Wang, H., Jiang, H., Chen, E., Zhang, J. and Xie, X. (2017) Apatinib for the Treatment of Pulmonary Epithelioid Hemangioendothelioma: A Case Report and Literature Review. Medicine (Baltimore), 96, e8507. https://doi.org/10.1097/MD.0000000000008507
|
[6]
|
Sebastian, A.S., Adair, M.J., Morris, J.M., Khan, M.H., Arndt, C.A. and Nassr, A. (2015) Minimally Invasive Treatment of a Painful Osteolytic Lumbar Lesion Secondary to Epithelioid Hemangioendothelioma. Global Spine Journal, 5, 135-139. https://doi.org/10.1055/s-0034-1387198
|
[7]
|
Albakr, A., Schell, M., Drew, B. and Cenic, A. (2017) Epithelioid Hemangioendothelioma of the Spine: Case Report and Review of the Literature. Journal of Spine Surgery, 3, 250-259. https://doi.org/10.21037/jss.2017.05.05
|
[8]
|
Ennouhi, M.A., Guerrouani, A. and Moussaoui, A. (2018) Epithelioid Hemangioendothelioma, an Uncommon Tumor of the Eyelid: A Case Report. Journal of Stomatology, Oral and Maxillofacial Surgery, 119, 40-43. https://doi.org/10.1016/j.jormas.2017.10.001
|
[9]
|
Harada, J., Yoshida, H., Ueda, J., Mamada, Y., Taniai, N., Mineta, S., Yoshioka, M., Kawano, Y., Shioda, Y. and Uchida, E. (2011) Malignant Hepatic Epithelioid Hemangioendothelioma with Abdominal Pain due to Rapid Progression. Journal of Nippon Medical School, 78, 246-251.
|
[10]
|
Mark, J., Argentieri, D.M., Gutierrez, C.A., Morrell, K., Eng, K., Hutson, A.D., Mayor, P., Szender, J.B., Starbuck, K., Lynam, S., Blum, B., Akers, S., Lele, S., Paragh, G., Odunsi, K., de Leon-Casasola, O., Frederick, P.J. and Zsiros, E. (2018) Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery. JAMA Network Open, 1, e185452. https://doi.org/10.1001/jamanetworkopen.2018.5452
|
[11]
|
Kumar, V., Garg, R., Bharati, S.J., Gupta, N., Bhatanagar, S., Mishra, S. and Balhara, Y.P. (2015) Long-Term High-Dose Oral Morphine in Phantom Limb Pain with No Addiction Risk. Indian Journal of Palliative Care, 21, 85-87. https://doi.org/10.4103/0973-1075.150198
|
[12]
|
Aalae, I.S. and Jakate, S. (2005) Right Upper Quadrant Pain and Fever in a 41-Year-Old Man. Epithelioid Hemangioendothelioma of the Liver with Metastasis to Porta Hepatis Lymph Nodes and Lung. Archives of Pathology & Laboratory Medicine, 129, e134-e135.
|
[13]
|
Makhlouf, H.R., Ishak, K.G. and Goodman, Z.D. (1999) Epithelioid Hemangioendothelioma of the Liver: A Clinicopathologic Study of 137 Cases. Cancer, 85, 562-582. https://doi.org/10.1002/(SICI)1097-0142(19990201)85:3<5 62::AID-CNCR7>3.0.CO;2-T
|
[14]
|
Saffier, K., Colombo, C., Brown, D., Mundt, M.P. and Fleming, M.F. (2007) Addiction Severity Index in a Chronic Pain Sample Receiving Opioid Therapy. Journal of Substance Abuse Treatment, 33, 303-311. https://doi.org/10.1016/j.jsat.2006.12.011
|
[15]
|
Weiss, R.D. and Rao, V. (2017) The Prescription Opioid Addiction Treatment Study: What Have We Learned. Drug and Alcohol Dependence, 173, S48-S54. https://doi.org/10.1016/j.drugalcdep.2016.12.001
|
[16]
|
Cooper, Z.D., Johnson, K.W., Pavlicova, M., Glass, A., Vosburg, S.K., Sullivan, M.A., Manubay, J.M., Martinez, D.M., Jones, J.D., Saccone, P.A. and Comer, S.D. (2016) The Effects of Ibudilast, a Glial Activation Inhibitor, on Opioid Withdrawal Symptoms in Opioid-Dependent Volunteers. Addiction Biology, 21, 895-903. https://doi.org/10.1111/adb.12261
|
[17]
|
Oshima, N., Terajima, H. and Hosotan, I.R. (2009) Surgical Therapy for a Solitary Form of Hepatic Epithelioid Hemangioendothelioma: A Long-Term Survival Case. Case Reports in Gastroenterology, 3, 214-221. https://doi.org/10.1159/000227734
|
[18]
|
Ciliberti, M.P., Caponio, R., Pascali, A., Matichecchia, G. and Lioce, M. (2015) A Rare Case of Intravascular Epithelioid Hemangioendothelioma of the Cephalic Vein Treated with Surgery and Postoperative Radiation Therapy: A Case Report and Review of the Literature. Journal of Medical Case Reports, 9, 91. https://doi.org/10.1186/s13256-015-0565-0
|
[19]
|
Soape, M.P., Verma, R., Payne, J.D., Wachtel, M., Hardwicke, F. and Cobos, E. (2015) Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine. Case Reports in Gastrointestinal Medicine, 2015, Article ID: 326795. https://doi.org/10.1155/2015/326795
|
[20]
|
Mehrabi, A., Kashfi, A., Fonouni, H., Schemmer, P., Schmied, B.M., Hallscheidt, P., Schirmacher, P., Weitz, J., Friess, H., Buchler, M.W. and Schmidt, J. (2006) Primary Malignant Hepatic Epithelioid Hemangioendothelioma: A Comprehensive Review of the Literature with Emphasis on the Surgical Therapy. Cancer, 107, 2108-2121. https://doi.org/10.1002/cncr.22225
|
[21]
|
Nosek, K., Leppert, W., Nosek, H., Wordliczek, J. and Onichimowski, D. (2017) A Comparison of Oral Controlled-Release Morphine and Oxycodone with Transdermal Formulations of Buprenorphine and Fentanyl in the Treatment of Severe Pain in Cancer Patients. Drug Design, Development and Therapy, 11, 2409-2419. https://doi.org/10.2147/DDDT.S141007
|
[22]
|
Bercovitch, M. and Adunsky, A. (2004) Patterns of High-Dose Morphine Use in a Home-Care Hospice Service: Should We Be Afraid of It? Cancer, 101, 1473-1477. https://doi.org/10.1002/cncr.20485
|
[23]
|
Chatham, M.S., Dodds Ashley, E.S., Svengsouk, J.S. and Juba, K.M. (2013) Dose Ratios between High Dose Oral Morphine or Equivalents and Oral Methadone. Journal of Palliative Medicine, 16, 947-950. https://doi.org/10.1089/jpm.2012.0434
|
[24]
|
Lin, X., Wang, Y.J., Li, Q., Hou, Y.Y., Hong, M.H., Cao, Y.L., Chi, Z.Q. and Liu, J.G. (2009) Chronic High-Dose Morphine Treatment Promotes SH-SY5Y Cell Apoptosis via c-Jun N-Terminal Kinase-Mediated Activation of Mitochondria-Dependent Pathway. The FEBS Journal, 276, 2022-2036. https://doi.org/10.1111/j.1742-4658.2009.06938.x
|
[25]
|
Donaldson, R., Sun, Y., Liang, D.Y., Zheng, M., Sahbaie, P., Dill, D.L., Peltz, G., Buck, K.J. and Clark, J.D. (2016) The Multiple PDZ Domain Protein Mpdz/MUPP1 Regulates Opioid Tolerance and Opioid-Induced Hyperalgesia. BMC Genomics, 17, 313. https://doi.org/10.1186/s12864-016-2634-1
|
[26]
|
Hua, Z., Liu, L., Shen, J., Cheng, K., Liu, A., Yang, J., Wang, L., Qu, T., Yang, H., Li, Y., Wu, H., Narouze, J., Yin, Y. and Cheng, J. (2017) Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia. Scientific Reports, 7, Article No. 40978. https://doi.org/10.1038/srep40978
|
[27]
|
Patch, R.K., Eldrige, J.S., Moeschler, S.M. and Pingree, M.J. (2017) Dexmedetomidine as Part of a Multimodal Analgesic Treatment Regimen for Opioid Induced Hyperalgesia in a Patient with Significant Opioid Tolerance. Case Reports in Anesthesiology, 2017, Article ID: 9876306. https://doi.org/10.1155/2017/9876306
|
[28]
|
Woodward, O.B., Naraen, S. and Naraen, A. (2017) Opioid-Induced Myoclonus and Hyperalgesia Following a Short Course of Low-Dose Oral Morphine. British Journal of Pain, 11, 32-35. https://doi.org/10.1177/2049463716664371
|
[29]
|
Borjkhani, M., Bahrami, F. and Janahmadi, M. (2018) Computational Modeling of Opioid-Induced Synaptic Plasticity in Hippocampus. PLoS ONE, 13, e0193410. https://doi.org/10.1371/journal.pone.0193410
|
[30]
|
Chen, S.L., Tao, P.L., Chu, C.H., Chen, S.H., Wu, H.E., Tseng, L.F., Hong, J.S. and Lu, R.B. (2012) Low-Dose Memantine Attenuated Morphine Addictive Behavior through Its Anti-Inflammation and Neurotrophic Effects in Rats. Journal of Neuroimmune Pharmacology, 7, 444-453. https://doi.org/10.1007/s11481-011-9337-9
|